Lv33
390 积分 2024-01-02 加入
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
1个月前
已完结
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
1个月前
已完结
The cardiometabolic safety of dupilumab in atopic dermatitis: A global large-scale cohort study
1个月前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
2个月前
已完结
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
2个月前
已完结
Antirheumatic drugs in reproduction, pregnancy, and lactation: a systematic literature review informing the 2024 update of the EULAR recommendations
5个月前
已关闭
Maternal emotional distress and infant sleep: A longitudinal study from pregnancy through 18 months
5个月前
已完结
Chronic Urticaria in Special Populations
5个月前
已完结
IL-4-induced decrease in both the number and CTLA-4 expression of Treg impairs suppression of Th2 type inflammation in severe atopic dermatitis
5个月前
已完结
皖公网安备34019202002308
